{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:24:35Z","timestamp":1785183875476,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>NARS2<\/jats:italic>\n                      gene encodes mitochondrial asparaginyl-tRNA synthetase, and biallelic pathogenic variants have been associated with combined oxidative phosphorylation deficiency 24 (COXPD24), an autosomal recessive mitochondrial disorder characterized by highly heterogeneous clinical manifestations. This study retrospectively analyzed the clinical and genetic findings of a Chinese infant presenting with status epilepticus and explored potential genotype\u2013phenotype correlations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical data, laboratory tests, neuroimaging, and disease course of the proband were reviewed. Whole-exome sequencing (WES) and copy-number variation (CNV) analysis were performed to identify causative variants in\n                      <jats:italic>NARS2<\/jats:italic>\n                      . Candidate variants were assessed by population database screening and literature review.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The proband, a 9-month-old girl, presented with status epilepticus, global developmental delay, increased muscle tone, elevated serum lactate and myocardial enzyme levels. Brain magnetic resonance imaging (MRI) revealed a focal cerebral lesion consistent with a metabolic or stroke-like infarction, as well as delayed myelination. WES identified compound heterozygous\n                      <jats:italic>NARS2<\/jats:italic>\n                      variants: a large exon 6\u201311 deletion and a novel missense variant c.467T&amp;gt;C (p.Leu156Ser), inherited in an autosomal recessive manner. Both variants were absent from public population databases and published literature. Notably, cerebral infarction has not been previously reported in\n                      <jats:italic>NARS2<\/jats:italic>\n                      -related disorders, suggesting a potential expansion of the clinical spectrum.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Review of previously reported\n                      <jats:italic>NARS2<\/jats:italic>\n                      variants indicates that both missense and loss-of-function mutations can lead to variable disease severity depending on residual enzyme activity. This case broadens the phenotypic and mutational spectrum of\n                      <jats:italic>NARS2<\/jats:italic>\n                      -associated COXPD24 and highlights the importance of evaluating large exon deletions and novel variants in infants with early-onset mitochondrial encephalopathy and epileptic manifestations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1731858","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:09:36Z","timestamp":1764954576000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Stroke-like lesion and status epilepticus in a child with NARS2-related combined oxidative phosphorylation deficiency 24"],"prefix":"10.3389","volume":"16","author":[{"given":"Song","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/07391102.2012.689701","article-title":"Mechanism of the activation step of the aminoacylation reaction: a significant difference between class I and class II synthetases","volume":"30","author":"Banik","year":"2012","journal-title":"J Biomol Struct Dyn"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s11845-021-02736-7","article-title":"Novel phenotype and genotype spectrum of NARS2 and literature review of previous mutations","volume":"191","author":"Vafaee-Shahi","year":"2022","journal-title":"Ir J Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/nar\/gkw1182","article-title":"The complex evolutionary history of aminoacyl-tRNA synthetases","volume":"45","author":"Chaliotis","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.21037\/tp-21-570","article-title":"Study of novel NARS2 variants in patient of combined oxidative phosphorylation deficiency 24","volume":"11","author":"Zhang","year":"2022","journal-title":"Transl Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pediatrneurol.2018.07.014","article-title":"Lethal NARS2-related disorder associated with rapidly progressive intractable epilepsy and global brain atrophy","volume":"89","author":"Seaver","year":"2018","journal-title":"Pediatr Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e1005097","DOI":"10.1371\/journal.pgen.1005097","article-title":"Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA synthetase, cause nonsyndromic deafness and Leigh syndrome","volume":"11","author":"Simon","year":"2015","journal-title":"PLoS Genet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejpn.2021.01.012","article-title":"The phenotypic variability and natural history of NARS2 associated disease","volume":"31","author":"Sofou","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e31467","DOI":"10.7759\/cureus.31467","article-title":"Bilateral nonsyndromic sensorineural hearing loss caused by a NARS2 mutation","volume":"14","author":"Al-Sharif","year":"2022","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1076183","DOI":"10.3389\/fnins.2022.1076183","article-title":"Clinical and genetic analyses of premature mitochondrial encephalopathy with epilepsia partialis continua caused by novel biallelic NARS2 mutations","volume":"16","author":"Hu","year":"2022","journal-title":"Front Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2024.10.007","article-title":"CCDC22 variants caused X-linked focal epilepsy and focal cortical dysplasia","volume":"123","author":"He","year":"2024","journal-title":"Seizure"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1321090","DOI":"10.3389\/fnmol.2023.1321090","article-title":"De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects","volume":"16","author":"Liu","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1111\/epi.18358","article-title":"De novo TANC2 variants caused developmental and epileptic encephalopathy and epilepsy","volume":"66","author":"Luo","year":"2025","journal-title":"Epilepsia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1081097","DOI":"10.3389\/fnmol.2022.1081097","article-title":"Expanding the phenotypic spectrum of KCNK4: from syndromic neurodevelopmental disorder to rolandic epilepsy","volume":"15","author":"Yan","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1499716","DOI":"10.3389\/fgene.2025.1499716","article-title":"De novo KCNK4 variant caused epilepsy with febrile seizures plus, neurodevelopmental abnormalities, and hypertrichosis","volume":"16","author":"Yan","year":"2025","journal-title":"Front Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"9951922","DOI":"10.1155\/humu\/9951922","article-title":"De novo ACTB variant associated with juvenile-onset temporal lo be epilepsy with favorable outcomes","volume":"2025","author":"Yan","year":"2025","journal-title":"Hum Mutat"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"101473","DOI":"10.1016\/j.gendis.2024.101473","article-title":"CSMD1 is a causative gene of developmental and epileptic encephalopathy and generalized epilepsies","volume":"12","author":"Zhang","year":"","journal-title":"Genes Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/hmg\/ddae104","article-title":"Investigation in yeast of novel variants in mitochondrial aminoacyl-tRNA synthetases WARS2, NARS2, and RARS2 genes associated with mitochondrial diseases","volume":"33","author":"Figuccia","year":"2024","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12887-024-04553-0","article-title":"Novel NARS2 variants in a patient with early-onset status epilepticus: case study and literature review","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1571426","DOI":"10.3389\/fped.2025.1571426","article-title":"Compound heterozygous variants of the NARS2 gene in siblings with refractory seizures: two case report and literature review","volume":"13","author":"Wu","year":"2025","journal-title":"Front Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3174\/ajnr.A7837","article-title":"MELAS: phenotype classification into classic-versus-atypical presentations","volume":"44","author":"Alves","year":"2023","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metab"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/biomedicines13061338","article-title":"Involvement of oxidative stress in mitochondrial abnormalities during the development of heart disease","volume":"13","author":"Dhalla","year":"2025","journal-title":"Biomedicine"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"155365","DOI":"10.1016\/j.phymed.2024.155365","article-title":"Salidroside pretreatment alleviates ferroptosis induced by myocardial ischemia\/reperfusion through mitochondrial superoxide-dependent AMPK\u03b12 activation","volume":"128","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e80815","DOI":"10.1371\/journal.pone.0080815","article-title":"AKIP1 expression modulates mitochondrial function in rat neonatal cardiomyocytes","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/humu.22728","article-title":"Two siblings with homozygous pathogenic splice-site variant in mitochondrial asparaginyl-tRNA synthetase (NARS2)","volume":"36","author":"Vanlander","year":"2015","journal-title":"Hum Mutat"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/jhg.2016.163","article-title":"PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder","volume":"62","author":"Mizuguchi","year":"2017","journal-title":"J Hum Genet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2018.11.013","article-title":"Reply to Finsterer regarding lethal NARS2-related disorder associated with rapidly progressive intractable epilepsy and global brain atrophy","volume":"93","author":"Seaver","year":"2019","journal-title":"Pediatr Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/cge.13713","article-title":"Genetic heterogeneity in Leigh syndrome: highlighting treatable and novel genetic causes","volume":"97","author":"Lee","year":"2020","journal-title":"Clin Genet"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00439-020-02187-7","article-title":"Autozygosity-driven genetic diagnosis in consanguineous families from Italy and the greater Middle East","volume":"139","author":"Palombo","year":"2020","journal-title":"Hum Genet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10048-021-00659-0","article-title":"Novel variants in the NARS2 gene as a cause of infantile-onset severe epilepsy leading to fatal refractory status epilepticus: case study and literature review","volume":"22","author":"\u0160t\u011brbov\u00e1","year":"2021","journal-title":"Neurogenetics"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/ajmg.a.62873","article-title":"Compound heterozygous variants of the NARS2 gene in siblings with developmental delay, epilepsy, and neonatal diabetes syndrome","volume":"188","author":"Yagasaki","year":"2022","journal-title":"Am J Med Genet A"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/ajmg.a.62641","article-title":"Whole-exome sequencing identified novel variants in three Chinese Leigh syndrome pedigrees","volume":"188","author":"Yang","year":"2022","journal-title":"Am J Med Genet A"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41439-022-00191-z","article-title":"Novel NARS2 variant causing leigh syndrome with normal lactate levels","volume":"9","author":"Tanaka","year":"2022","journal-title":"Hum Genome Var"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"fmac108","DOI":"10.1093\/tropej\/fmac108","article-title":"A new entity in the NARS2 variant: the first reported case of type 1 diabetes mellitus associated with the phenotype","volume":"69","author":"Cokyaman","year":"2022","journal-title":"J Trop Pediatr"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"104643","DOI":"10.1016\/j.ejmg.2022.104643","article-title":"Splicing variants in NARS2 are associated with milder phenotypes and intra-familial variability","volume":"65","author":"Ait-El-Mkadem Saadi","year":"2022","journal-title":"Eur J Med Genet"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e43969","DOI":"10.7759\/cureus.43969","article-title":"Progressive mitochondrial encephalopathy due to the novel compound heterozygous variants c.182C>T and c.446A>AG in NARS2: a case report","volume":"15","author":"Finsterer","year":"2023","journal-title":"Cureus"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1731858\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:09:36Z","timestamp":1764954576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1731858\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":40,"alternative-id":["10.3389\/fneur.2025.1731858"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1731858","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"article-number":"1731858"}}